webmeeting
webmeeting with http://www.mdnewscast.net

webmeeting

Medical Newscast

News for 17-Sep-26

Source: MedicineNet High Blood Pressure General
Yoga Called Good Medicine for High Blood Pressure

Source: MedicineNet Diabetes General
Daily Can of Soda Boosts Odds for Prediabetes, Study Finds

Source: MedicineNet Diabetes General
Health Tip: Creating an Insulin Routine

Source: MedicineNet High Blood Pressure General
Omega-3s a Recipe for Healthy Blood Pressure in Young Adults

Source: MedicineNet High Blood Pressure General
High Blood Pressure Rates Have Doubled Worldwide Since 1975

Source: MedicineNet High Blood Pressure General
Sharp Drop in Blood Pressure After Rx May Be Risky for Some Heart Patients

Source: MedicineNet Diabetes General
Chemo More Damaging to Hearts of Diabetics: Study

Source: MedicineNet High Blood Pressure General
High Blood Pressure Might Affect Some Kids' Thinking Ability

Source: MedicineNet Diabetes General
Insulin Prices Skyrocket, Putting Many Diabetics in a Bind

Source: MedicineNet High Blood Pressure General
Stressed Childhood Might Raise Risk for High Blood Pressure Later

Search the Web
webmeeting
net meetings
audioconférence
meeting place
imeet
webcross
audiographic
centra
conferencing
telecast

The Best webmeeting website

All the webmeeting information you need to know about is right here. Presented and researched by http://www.mdnewscast.net. We've searched the information super highway far and wide to provide you with the best webmeeting site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
webmeeting.

webmeeting

Medical Newscast
For information about Medical Newscasts look no further. We have links to great resources regarding all forms of medical internet broadcasting.
Medical Newscast

Shopping for webmeeting



When you’re shopping for webmeeting you’ve come to the right place. We’re specialists in this webmeeting field. You can’t find exactly what you’re looking for on too many other sites, but you can here.

Well maybe that’s a slight exaggeration. We might not have got exactly what you’re looking for – webmeeting – but we know the very best websites to get it from. All you have to do is follow the links below. They’re the very best webmeeting sites you’re going to find anywhere, and they’re the ones we use ourselves when we want to get information or make a purchase.

How do we know they’re the best webmeeting websites available on the net today? Because we’ve spent months painstakingly researching the subject. We’ve visited every site about webmeeting we could find, and we’ve studied them to sort the good from the bad.

Look, we’re good at getting ranked well in search engines. webmeeting might be our big interest, but we’ll be the first to admit that out site doesn’t come anywhere near the quality of the websites we’re linking to. So what we suggest you do is follow one the links. You won’t be disappointed. Thanks for visiting our webpage, and please come back again one day. Next time you visit you might find that we’re the best webmeeting place online.

webmeeting

Medical Newscast
For information about Medical Newscasts look no further. We have links to great resources regarding all forms of medical internet broadcasting.
Medical Newscast

The links will take you to web sites we judge have been created by experts in the field of webmeeting, and that will become obvious to you also as soon as you arrive at the sites. However we know that everyone is different in their webmeeting requirements and suggest if you don't find what you are looking for at the above sites, visit Yahoo which is arguably the best search engine on the net, and then perform a search on webmeeting.

We might mention that yahoo is by no means your only search engine option when you are looking for webmeeting information, other search engines are google alta vista, hotbot, msn, etc which should all produce good webmeeting results.

a Cold; Starve a Tumor

 by: ARA Content

(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it.

At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor.

The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size.

Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful.

One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review.

Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients.

If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.

About The Author

Courtesy ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com

Google

http://www.medmeet.com/
Forum On The Net | medical mailings | Medical Presentations | Go Antiques | Medical Newscast

MD Meetings   Real Time Media On The Net   Law Meet